Current Position and Role at DeLorean Artificial Intelligence (DAI)
Severence MacLaughlin, Ph.D, serves as the Founder, Chief Executive Officer (CEO), and Managing Partner of DeLorean Artificial Intelligence (DAI), a company he established in November 2020. In this capacity, Dr. MacLaughlin directs the development and deployment of sentient and semi-sentient AI systems aimed at solving intricate corporate and organizational challenges, with a particular focus on healthcare and sales sectors. Under his leadership, DAI specializes in highly advanced artificial intelligence applications that integrate biological validation approaches to predictive medicine, representing a pioneering move away from reactive healthcare models towards predictive intervention.
Expertise and Industry Standing
Dr. MacLaughlin is recognized globally as a top-ranked data scientist in both artificial intelligence (AI) and life sciences data science domains. He is consistently ranked among the top 20 life sciences data scientists worldwide and holds the distinction of being the second-ranked healthcare data scientist globally. His professional impact extends beyond corporate leadership; he also serves as a trusted advisor to the United Nations (UN) and is noted for his blockchain strategy expertise in addition to AI and data science.
Educational Background
- Bachelor of Science (B.Sc.), Magna Cum Laude with Honors & Distinction, Cornell University.
- Doctorate (Ph.D.), Honors, top 1% in Embryonic and Fetal Development, University of Adelaide (2001-2006).
- Professor of Neurodiversity and Developmental Psychology at the University of Cambridge (noted in professional affiliations).
Key Achievements and Contributions
- Successfully delivered over 40 disruptive technologies and Systems of Intelligence, generating more than $1.8 billion in net present value for customers and partners.
- Oversaw a landmark AI technology achievement where DeLorean AI’s system outperformed Salesforce CRM’s native AI capabilities when applied to CRM predictive analytics—establishing a technology superiority benchmark.
- Guided the development of DeLorean AI’s predictive renal AI, which demonstrated a 50% reduction in patient hospitalizations within 60 days at a major health provider (Atlantic), showcasing the commercial and clinical efficacy of DeLorean AI's products.
- Spearheaded the expansion of DAI’s offerings into mental health AI systems, specifically targeting depression and other psychiatric conditions through predictive medicine platforms.
- Positioned DeLorean AI as an emerging gold standard in healthcare AI, with future aspirations to become analogous to Intel’s role in computing with respect to quality and influence in artificial intelligence.
Public Presence and Thought Leadership
- Active speaker and thought leader, featured in multiple industry summits including the Healthcare Transformation Summit.
- Published and featured in recent Q&A interviews discussing topics such as predictive medicine, bootstrapping AI startups, and integrating biological data into AI frameworks.
- Maintains a professional online presence on LinkedIn ([profile](http://www.linkedin.com/in/severence-maclaughlin-ph-d-a759475)) and on the X social platform as @severencemacla1, where he shares insights on AI in healthcare transformation.
- Delivered in-depth interviews and presentations, including notable YouTube presence where he discusses both DeLorean AI's technology roadmap and the broader implications of AI in healthcare and corporate environments.
Company Profile – DeLorean Artificial Intelligence (DAI)
Founded and led by Dr. MacLaughlin, DeLorean AI develops advanced sentient and semi-sentient AI systems that address complex sectorial problems, specializing in healthcare predictive analytics and enterprise intelligence. The company focuses on producing biologically validated AI solutions that tackle chronic conditions such as renal diseases, with longitudinal evidence of performance improvements. DAI’s mission is to transform healthcare delivery by shifting from traditional reactive models to predictive, data-driven care pathways. The firm is also expanding its impact into sales and consumer packaged goods (CPG) through AI-driven intelligence systems.
Strategic Outlook
Dr. MacLaughlin envisages DeLorean AI positioning itself as a defining leader in AI quality standards, comparable to the influence historically held by legacy technology corporations in their respective sectors. This ambition drives ongoing innovation within the company’s portfolio and underpins efforts to achieve meaningful return on investment (ROI) and demonstrable patient and client outcomes, enhancing operational efficiency and lowering associated healthcare costs.
This profile encapsulates Dr. Severence MacLaughlin’s professional background, leadership role, educational credentials, and sector influence, offering a data-driven overview relevant for engagement with DeLorean Artificial Intelligence’s business and technology initiatives.
